349 Highly potent tumor-targeting optimally primed natural killer cells produced under a feeder-cell free condition in a 50L-scale bioreactor with cytokine-fusion proteins elicits robust anti-tumor response in preclinical study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.